farmaco semaglutide Novo Nordisk's shortage officially concludes in the US, spelling major threat for weight loss drug compounders Compounded Semaglutide
Description
GLP-1 compounding faces legal challenges, evolving FDA rules, and heightened enforcement risks.
We present the case of a 32-year-old woman with no prior medical history who developed hematochezia and abdominal pain after six weeks of tirzepatide therapy for weight loss
When clients started asking me about Ozempic and Mounjaro, I pretty much tried to keep my head firmly in the sand
Discover how keto does what GLP-1 agonists promise.
Eli Lilly has just launched its newly approved GLP-1 product, Zepbound, in a direct-to-consumer approach
